1[1]Goodison S, Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology, 1998,32(1):1
2[2]Stickeler E, Mobus VJ, Kieback DG, et al.Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer. Anticancer Res,1997,17(6D):4395
3[3]Yoshida K, Bolodeoku J, Sugino T,et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumours. Cancer Res, 1995,55(19):4273
4[4]Nagabhushan M, Pretlow TG, Guo YJ,et al. Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol, 1996, 106(6):647
5[5]Mackay CR , Terpe HJ, Stauder R,et al. Expression and modulation of CD44 viariant isoforms in humans .J Cell Biol,1994,124(1-2):71
6[6]Saegusa M, Hashimura M, Okayasu I. CD44 expression in normal, hyperplastic, and malignant endometrium . J Pathol , 1998 ,184(3):297
7[7]Leblanc M, Poncelet C, Soriano D, et al. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchows Arch , 2001,438(1):78
6TOMIK J, SKADZIEN J, MODRZEJEWSKI M, et al. Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx[J]. Auris Nasus Larynx, 2001,28 : 233-- 240.
7WELCH D R, RINKER-SCHAEFFER C W. What defines a useful marker of metastasis in human cancer [J]? J Nat Cancer Ins,1999,91:1351--1353.
8STEEG P S. Metastasis suppressors alter the signal transduction of cancer cells [J]. Nat Rev Cancer, 2003, 3: 55--63.
9YOSHIDA B A, SOKOLOFF M M, WELCH D R, et al. Metastasis suppressor genes: a review and perspective on an emerging field[J]. J Natl Cancer Inst, 2000, 92: 1717--1730.
10KAUFFMAN E C, ROBINSON V L, STADLER W M,et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site[J]. J Urol, 2003, 169: 1122-1133.
